Lifevantage Corp (LFVN) stock

LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 16/3023% below fair value

$4.97−0.07 (-1.39%)

Close on Nov 13, 2026Market cap $62.26MP/E 23.7Yield 3.72%

Lifevantage statistics

106 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 3, 2027 (estimated, after the close)
Last ex-dividend date: Dec 1, 2026
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $62.26M; $272.32M
Enterprise Value: $48.53M; $146.23M
PE Ratio: 23.67; 25.11
PS Ratio: 0.36; 3.66
PB Ratio: 1.87; 2.00
P/TBV Ratio: 2.08; 2.22
P/FCF Ratio: 7.15; 17.86
P/OCF Ratio: 4.76; 12.99

Enterprise valuationIndustry

EV / Sales: 0.28; 2.57
EV / EBITDA: 7.37; 16.50
EV / EBIT: 13.13; 19.31
EV / FCF: 5.57; 22.27

Share statisticsIndustry

Shares Outstanding: 13M; 58M
Shares Change (YoY): -3.83%; 10.8%
Shares Change (QoQ): 0.57%; 0.50%
Float: 9M; 49M
Shares Held by Insiders: 27.8%; 11.7%
Shares Held by Institutions: 47.2%; 56.4%

Short sellingIndustry

Short Interest: 906,622; –
Short Interest Change: -7.11%; -0.80%
Short % of Float: 10.0%; 9.01%
Short % of Shares Outstanding: 7.24%; 6.30%
Days to Cover: 42.11; 5.15

Stock price statisticsIndustry

52-Week High: $11.71; –
52-Week Low: $3.90; –
20-Day Moving Average: $5.58; –
50-Day Moving Average: $5.93; –
200-Day Moving Average: $5.85; –
Average True Range (14): $0.36; –
Price Change (1 Week): -4.79%; -1.15%
Price Change (1 Month): -17.2%; -4.87%
Price Change (3 Months): -23.8%; -21.0%
Price Change (6 Months): -3.87%; -20.6%
Price Change (YTD): -19.3%; -23.6%
Price Change (1 Year): -25.2%; -22.4%
Price Change (3 Years): 6.88%; -29.5%
Price Change (5 Years): -30.5%; -77.9%
Price Change (10 Years): -33.4%; -65.4%
Average Volume (10 Days): 54,539; –
Average Volume (20 Days): 38,561; –
Average Volume (90 Days): 53,207; –
Relative Volume: 2.09; 0.70
Relative Strength Index (14): 36.9; 43.4
Volatility (1 Year): 74.6%; 80.1%
Beta (5 Years): 0.39; 1.07

MarginsIndustry

Gross Margin: 76.5%; 53.1%
Operating Margin: 2.15%; -38.7%
Pretax Margin: 2.12%; -11.6%
Profit Margin: 1.58%; -31.6%
EBITDA Margin: 3.83%; -27.7%
FCF Margin: 5.06%; -9.56%

Returns on capitalIndustry

Return on Equity (ROE): 8.19%; -49.9%
Return on Assets (ROA): 4.51%; -40.6%
Return on Invested Capital (ROIC): 14.0%; -32.9%
Return on Capital Employed (ROCE): 8.99%; -37.9%

Financial positionIndustry

Current Ratio: 1.91; 3.30
Quick Ratio: 0.86; 2.39

GrowthIndustry

Revenue Growth (YoY): -24.8%; 6.82%
Net Income Growth (YoY): -73.1%; -14.4%
EPS Growth (YoY): -72.7%; -12.3%
FCF Growth (YoY): 0.14%; 6.85%
Revenue Growth (3Y CAGR): -5.07%; 2.25%
Revenue Growth (5Y CAGR): -3.68%; 6.41%
EPS Growth (3Y CAGR): 26.0%; 1.30%
EPS Growth (5Y CAGR): -15.0%; 3.78%

EfficiencyIndustry

Asset Turnover: 2.85; 0.40
Inventory Turnover: 2.32; 2.73
Revenue Per Employee: $771.93K; $429.29K
Profits Per Employee: $12.20K; -$689.41K
Employee Count: 223; 74
WACC: 7.60%; 10.2%

Income statement (TTM)Industry

Revenue: $172.14M; $66.37M
Gross Profit: $131.77M; $120.78M
Operating Income: $3.70M; -$21.37M
Pretax Income: $3.64M; -$12.95M
Net Income: $2.72M; -$22.35M
EBITDA: $6.59M; -$17.21M
EPS (Diluted): $0.21; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $13.73M; $68.68M
Net Cash (Debt): $13.73M; $17.76M
Net Cash Per Share: $1.10; $0.80
Equity (Book Value): $33.26M; $53.89M
Book Value Per Share: $2.65; $1.50
Tangible Book Value: $29.86M; $27.13M
Working Capital: $16.45M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: $13.08M; -$12.38M
Capital Expenditures: -$4.37M; -$1.00M
Free Cash Flow: $8.71M; -$18.21M
FCF Per Share: $0.70; -$0.42

Dividends and yieldsIndustry

Earnings Yield: 4.37%; -21.8%
FCF Yield: 14.0%; -9.44%
Dividend Yield: 3.72%; 1.88%
Buyback Yield: 2.35%; -0.76%
Shareholder Yield: 6.08%; 0.00%
Dividend Per Share: $0.18; $0.83
Dividend Growth (YoY): 12.1%; 2.37%
Years of Dividend Growth: 1; 0
Payout Ratio: 88.2%; 55.4%
FCF Payout Ratio: 27.6%; 43.7%

Taxes and interestIndustry

Income Tax: $920.00K; $73.00K
Effective Tax Rate: 25.3%; 20.9%

Scores and fair valueIndustry

Graham Number: $3.54; $19.34
Graham Upside: -28.7%; -46.6%
Altman Z-Score: 2.42; 0.23
Piotroski F-Score: 6; 4
Beneish M-Score: -2.73; -2.63

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	LFVN	S&P 500	Difference	LFVN per year	S&P 500 per year
1 month	-16.5%	-3.0%	−13.4 pts
3 months	-22.8%	-2.8%	−20.0 pts
Year to date	-17.4%	+11.5%	−28.8 pts
1 year	-20.8%	+13.5%	−34.3 pts
3 years	+20.8%	+77.7%	−56.9 pts	+6.5%	+21.1%
5 years	-18.3%	+72.6%	−90.9 pts	-4.0%	+11.5%
10 years	-23.5%	+308.2%	−331.6 pts	-2.6%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M LFVN shares were sold short on Oct 30, 2026, down 7.1% from the previous report, or 10.03% of the shares available to trade. At recent volumes it would take 42.1 days to buy them back. Over the last 20 sessions, 31.9% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	906,622	-7.1%	21,530	42.1
Oct 15, 2026	976,051	-8.6%	33,935	28.8
Sep 30, 2026	1,068,085	-6.1%	32,754	32.6
Sep 15, 2026	1,137,906	-6.8%	48,138	23.6
Aug 31, 2026	1,221,521	+1.1%	54,973	22.2
Aug 14, 2026	1,207,968	-4.4%	57,105	21.1
Jul 31, 2026	1,263,292	-13.9%	72,742	17.4
Jul 15, 2026	1,467,409	-21.8%	184,284	8.0
Jun 30, 2026	1,877,105	-33.5%	443,984	4.2
Jun 15, 2026	2,824,413	-20.3%	1,302,475	2.2
May 29, 2026	3,544,182	-1.3%	364,832	9.7
May 15, 2026	3,590,981	-6.8%	260,290	13.8